HIV & Aging Quality Improvement Initiative

A PI-NCPD, PI-CME and ABIM MOC Assessment Recognition Program project in the Center for Infectious Disease to improve ASCVD 10-year risk calculation and appropriate statin prescribing provided by BUSM CME/CNE.

Claiming Credit for This Activity

Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will then be prompted to claim your credit on the following page.

Use of Learner Data (MD Only): by completing the evaluation and attesting to meeting the meaningful participation requirements, you agree to allow us to share your completion data with the ACCME and the ABIM.

Target Audience

Physicians, Nurses, Pharmacists, and Medical Assistants in Infectious Disease.

Learning Objectives

  • Apply improvement science principles to mitigate local gaps in care delivery.
  • Apply skills of data collection, analysis, and interpretation to understand and improve clinical processes.
Course summary
Available credit: 
  • 30.00 ABIM MOC IV
  • 30.00 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 30.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • 30.00 MA Risk Management
  • 30.00 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
    • 30.00 ANCC Pharmacology
Course opens: 
01/04/2022
Course expires: 
06/04/2022
Rating: 
0

Disclosure of Commercial Support from Ineligible Companies
Funded by an independent educational grant from Gilead Sciences, Inc. 

Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Planning Committee Disclosures

  • Archana Asundi, MD, CME Course Director,  receives grant support from GlaxoSmithKline/ViiV, Roche, ZeroDiagnostics and Merck.
  • Nina Lin, MD, Expert Faculty Advisor, has served on specific topic Gilead Advisory Panels, and receives research support from GlaxoSmithKline/ViiV, Roche, Merck, and ZeroDiagnostics. 
  • Cassandra Pierre, MD, MPH, MSc (CME Co-Course Director), Annie Potter, MSN, MPH, NP (NCPD Nurse Advisor), Cammie Townsend, NP, MS/MBA, RN (NCPD Activity Provider Program Director), Emily Jansen, MPH (CME/NCPD Planning Committee), Natalie Sanfratello, MPH (CME/NCPD Planning Committee) have no relevant financial relationships to disclose.


 

 

 

ABIM Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Continuing Medical Education Credit
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this PI-CME activity for a maximum of 30 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

Nursing Continuing Professional Development Credit
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours: 30 of which 30 are eligible for pharmacology credit.

Available Credit

  • 30.00 ABIM MOC IV
  • 30.00 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 30.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • 30.00 MA Risk Management
  • 30.00 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
    • 30.00 ANCC Pharmacology
Please login or register to take this course.